Correvio   Report issue

For profit Phase 3 Phase 4
Founded: Geneva Switzerland (2008)
Status: Acquired by Advanz Pharma (2020)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (2)

Key: Correvio (0) Acquired (2)

amiodarone (cordarone) (2 trials)

vernakalant (11 trials)

Drugs in Phase 3 Trials (1)

Key: Correvio (0) Acquired (1)

oxypurinol (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 12
  • # of Trial APIs: 3